Lymphocyte-to-Monocyte Ratio as a Practical Biomarker for Immunotherapy Response in Hepatocellular Carcinoma.
1/5 보강
TL;DR
Among these agents, the combination of durvalumab and tremelimumab (Dur/Tre), known as the STRIDE regimen, has reshaped the treat-ment landscape of unresectable hepatocellular carcinoma.
OpenAlex 토픽 ·
Inflammatory Biomarkers in Disease Prognosis
Hepatocellular Carcinoma Treatment and Prognosis
Cancer Immunotherapy and Biomarkers
Among these agents, the combination of durvalumab and tremelimumab (Dur/Tre), known as the STRIDE regimen, has reshaped the treat-ment landscape of unresectable hepatocellular carcinoma.
APA
Satoshi Tanaka (2026). Lymphocyte-to-Monocyte Ratio as a Practical Biomarker for Immunotherapy Response in Hepatocellular Carcinoma.. Hepatology research : the official journal of the Japan Society of Hepatology, 56(4), 399-400. https://doi.org/10.1111/hepr.70093
MLA
Satoshi Tanaka. "Lymphocyte-to-Monocyte Ratio as a Practical Biomarker for Immunotherapy Response in Hepatocellular Carcinoma.." Hepatology research : the official journal of the Japan Society of Hepatology, vol. 56, no. 4, 2026, pp. 399-400.
PMID
41355725 ↗
같은 제1저자의 인용 많은 논문 (5)
- Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a exon 14 skipping mutation: A case report.
- Optimal timing of the cumulative dose and factors related to acute urinary toxicity in prostate cancer treated using magnetic resonance linear accelerator.
- [Intraventricular Tumor Surgery in the Neuroendoscopic Era].
- Development and evaluation of deep learning models for estimating the organ at-risk dose constraint from two-dimensional cine magnetic resonance imaging scans during irradiation.
- Incidental Finding of a Popliteal Artery Aneurysm Identified by Duplex Ultrasonography During Deep Vein Thrombosis Screening.